Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
July-2021 Volume 22 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation

  • Authors:
    • Yuxia Zhang
    • Jingzhi Chang
    • Weiwei Jiang
    • Xin Ye
    • Shanfeng Zhang
  • View Affiliations / Copyright

    Affiliations: Department of Biochemistry and Molecular Biology, Shangqiu Medical College, Shangqiu, Henan 476100, P.R. China, Department of Medical College, Shangqiu Institute of Technology, Shangqiu, Henan 476400, P.R. China, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, P.R. China
    Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 544
    |
    Published online on: May 20, 2021
       https://doi.org/10.3892/ol.2021.12805
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Previous studies have shown that lutein can inhibit the proliferation of breast cancer cells. However, the mechanism of lutein inhibiting the proliferation of breast cancer cells remains unclear. The present study aimed to determine whether the long non‑coding RNA (lncRNA) Cancer Susceptibility 9 (CASC9)/microRNA (miR)‑590‑3p axis participates in the antiproliferative effects of lutein via lncRNA microarray hybridization, reverse transcription‑quantitative PCR, dual‑luciferase reporter and MTT assays. The results demonstrated that CASC9 was the most significantly downregulated lncRNA in MCF7 cells treated with lutein. miR‑590‑3p was identified as the target of CASC9. In addition, lutein downregulated CASC9 expression and upregulated miR‑590‑3p expression in dose‑ and time‑dependent manners, respectively. CASC9 knockdown or overexpression of miR‑590‑3p inhibited the proliferation of breast cancer cells. Notably, simultaneous transfection with miR‑590‑3p mimics and CASC9 small interfering RNA increased the potency of lutein in inhibiting the proliferation of breast cancer cells. Taken together, these results suggest that the CASC9/miR‑590‑3p axis participates in the antiproliferative effects of lutein on breast cancer.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015. View Article : Google Scholar : PubMed/NCBI

2 

Benson JR, Jatoi I, Keisch M, Esteva FJ, Makris A and Jordan VC: Early breast cancer. Lancet. 373:1463–1479. 2009. View Article : Google Scholar : PubMed/NCBI

3 

Fan L, Strasser-Weippl K, Li JJ, St Louis J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Susini T, Olivieri S, Molino C, Castiglione F, Tavella K and Viligiardi R: Ovarian cancer initially presenting as intramammary metastases and mimicking a primary breast carcinoma: A case report and literature review. J Womens Health (Larchmt). 19:169–174. 2010. View Article : Google Scholar : PubMed/NCBI

5 

Kim HW, Chew BP, Wong TS, Park JS, Weng BB, Byrne KM, Hayek MG and Reinhart GA: Dietary lutein stimulates immune response in the canine. Vet Immunol Immunopathol. 74:315–327. 2000. View Article : Google Scholar : PubMed/NCBI

6 

Zou Z, Xu X, Huang Y, Xiao X, Ma L, Sun T, Dong P, Wang X and Lin X: High serum level of lutein may be protective against early atherosclerosis: The Beijing atherosclerosis study. Atherosclerosis. 219:789–793. 2011. View Article : Google Scholar : PubMed/NCBI

7 

Carpentier S, Knaus M and Suh M: Associations between lutein, zeaxanthin, and age-related macular degeneration: An overview. Crit Rev Food Sci. 49:313–326. 2009. View Article : Google Scholar : PubMed/NCBI

8 

Reynoso-Camacho R, González-Jasso E, Ferriz-Martínez R, Villalón-Corona B, Loarca-Piña GF, Salgado LM and Ramos-Gomez M: Dietary supplementation of lutein reduces colon carcinogenesis in DMH-treated rats by modulating K-ras, PκB, and β-catenin proteins. Nutr Cancer. 63:39–45. 2011.PubMed/NCBI

9 

Bharti AC and Aggarwal BB: Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization. Ann N Y Acad Sci. 973:392–395. 2002. View Article : Google Scholar : PubMed/NCBI

10 

Chang J, Zhang Y, Li Y, Lu K, Shen Y, Guo Y, Qi Q, Wang M and Zhang S: NrF2/ARE and NF-κB pathway regulation may be the mechanism for lutein inhibition of human breast cancer cell. Future Oncol. 14:719–726. 2018. View Article : Google Scholar : PubMed/NCBI

11 

García-Padilla C, Aránega A and Franco D: The role of long non-coding RNAs in cardiac development and disease. AIMS Genet. 5:124–140. 2018. View Article : Google Scholar

12 

Yu Y, Wang L, Li Z, Zheng Y, Shi Z and Wang G: Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p. J Biochem Mol Toxicol. 35:e227342021. View Article : Google Scholar : PubMed/NCBI

13 

Mei J, Hao L, Wang H, Xu R, Liu Y, Zhu Y and Liu C: Systematic characterization of non-coding RNAs in triple-negative breast cancer. Cell Prolif. 53:e128012020. View Article : Google Scholar : PubMed/NCBI

14 

Grixti JM and Ayers D: Long noncoding RNAs and their link to cancer. Noncoding RNA Res. 5:77–82. 2020. View Article : Google Scholar : PubMed/NCBI

15 

Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N and Hahne JC: MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: First steps from bench to bedside. Target Oncol. 15:261–278. 2020. View Article : Google Scholar : PubMed/NCBI

16 

Guan H, Shang G, Cui Y, Liu J, Sun X, Cao W, Wang Y and Li Y: Long noncoding RNA APTR contributes to osteosarcoma progression through repression of miR-132-3p and upregulation of yes-associated protein 1. J Cell Physiol. 234:8998–9007. 2019. View Article : Google Scholar : PubMed/NCBI

17 

Wu G, Xue M, Zhao Y, Han Y, Li C, Zhang S, Zhang J and Xu J: Long noncoding RNA ZEB1-AS1 acts as a Sponge of miR-141-3p to inhibit cell proliferation in colorectal cancer. Int J Med Sci. 17:1589–1597. 2020. View Article : Google Scholar : PubMed/NCBI

18 

Guan H, Liu J, Lv P, Zhou L, Zhang J and Cao W: MicroRNA-590 inhibits migration, invasion and epithelial-to-mesenchymal transition of esophageal squamous cell carcinoma by targeting low-density lipoprotein receptor-related protein 6. Oncol Rep. 44:1385–1392. 2020.PubMed/NCBI

19 

Sun P, Feng Y, Guo H, Li R, Yu P, Zhou X, Pan Z, Liang Y, Yu B, Zheng Y, et al: MiR-34a inhibits cell proliferation and induces apoptosis in human nasopharyngeal carcinoma by targeting lncRNA MCM3AP-AS1. Cancer Manag Res. 12:4799–4806. 2020. View Article : Google Scholar : PubMed/NCBI

20 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

21 

Ma W, Xue N, Zhang J, Wang D, Yao X, Lin L and Xu Q: circUBAP2 regulates osteosarcoma progression via the miR-204-3p/HMGA2 axis. Int J Oncol. 58:298–311. 2021. View Article : Google Scholar : PubMed/NCBI

22 

Ma W, Zhao X, Xue N, Gao Y and Xu Q: The LINC01410/miR-122-5p/NDRG3 axis is involved in the proliferation and migration of osteosarcoma cells. IUBMB Life. 73:705–717. 2021. View Article : Google Scholar : PubMed/NCBI

23 

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI

24 

Guestini F, McNamara KM, Ishida T and Sasano H: Triple negative breast cancer chemosensitivity and chemoresistance: Current advances in biomarkers indentification. Expert Opin Ther Targets. 20:705–720. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Echeverria GV, Powell E, Seth S, Ge Z, Carugo A, Bristow C, Peoples M, Robinson F, Qiu H, Shao J, et al: High-resolution clonal mapping of multi-organ metastasis in triple negative breast cancer. Nat Commun. 9:5079–5095. 2018. View Article : Google Scholar : PubMed/NCBI

26 

Xiong H, Shen J, Chen Z, Yang J, Xie B, Jia Y, Jayasinghe U, Wang J, Zhao W, Xie S, et al: H19/let 7/Lin28 ceRNA network mediates autophagy inhibiting epithelial mesenchymal transition in breast cancer. Int J Oncol. 56:794–806. 2020.PubMed/NCBI

27 

Scacalossi KR, van Solingen C and Moore KJ: Long non-coding RNAs regulating macrophage functions in homeostasis and disease. Vascul Pharmacol. 114:122–130. 2019. View Article : Google Scholar : PubMed/NCBI

28 

Liu KS, Li TP, Ton H, Mao XD and Chen YJ: Advances of long noncoding RNAs-mediated regulation in reproduction. Chin Med J (Engl). 131:226–234. 2018. View Article : Google Scholar : PubMed/NCBI

29 

Cortini F, Roma F and Villa C: Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease. Ageing Res Rev. 50:19–26. 2019. View Article : Google Scholar : PubMed/NCBI

30 

Schulte C, Barwari T, Joshi A, Zeller T and Mayr M: Noncoding RNAs versus protein biomarkers in cardiovascular disease. Trends Mol Med. 26:583–596. 2020. View Article : Google Scholar : PubMed/NCBI

31 

Su Y, Zhou LL, Zhang YQ and Ni LY: Long noncoding RNA HOTTIP is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation. Mol Genet Genomic Med. 7:e8702019. View Article : Google Scholar : PubMed/NCBI

32 

Yu Q, Zhao MW and Yang P: LncRNA UCA1 suppresses the inflammation via modulating miR-203-mediated regulation of MEF2C/NF-κB signaling pathway in epilepsy. Neurochem Res. 45:783–795. 2020. View Article : Google Scholar : PubMed/NCBI

33 

Guan H, Mei Y, Mi Y, Li C, Sun X, Zhao X, Liu J, Cao W, Li Y and Wang Y: Downregulation of lncRNA ANRIL suppresses growth and metastasis in human osteosarcoma cells. Onco Targets Ther. 11:4893–4899. 2018. View Article : Google Scholar : PubMed/NCBI

34 

Wang J, Sun J and Yang F: The role of long non-coding RNA H19 in breast cancer. Oncol Lett. 19:7–16. 2020.PubMed/NCBI

35 

Liu C, Jiang F, Zhang X and Xu X: Long non-coding RNA UCA1 modulates paclitaxel resistance in breast cancer via miR-613/CDK12 Axis. Cancer Manag Res. 12:2777–2788. 2020. View Article : Google Scholar : PubMed/NCBI

36 

Li Y, Guo XB and Wei YH: LncRNA GAS5 affects epithelial-mesenchymal transition and invasion of breast cancer cells by regulating miR-216b. Eur Rev Med Pharmacol Sci. 24:4873–4881. 2020.PubMed/NCBI

37 

Hu P, Chu J, Wu Y, Sun L, Lv X, Zhu Y, Li J, Guo Q, Gong C, Liu B and Su S: NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2. Oncotarget. 6:32410–23425. 2015. View Article : Google Scholar : PubMed/NCBI

38 

Wang Y, Zhou Y, Yang Z, Chen B, Huang W, Liu Y and Zhang Y: MiR-204/ZEB2 axis functions as key mediator for MALAT1-induced epithelial-mesenchymal transition in breast cancer. Tumour Biol. 39:10104283176909982017. View Article : Google Scholar : PubMed/NCBI

39 

Bida O, Gidoni M, Ideses D, Efroni S and Ginsberg D: A novel mitosis-associated lncRNA, MA-linc1, is required for cell cycle progression and sensitizes cancer cells to Paclitaxel. Oncotarget. 6:27880–27890. 2015. View Article : Google Scholar : PubMed/NCBI

40 

Wei F, Yang S and Wang S: MicroRNAs: A critical regulator under mechanical force. Histol Histopathol. 33:335–342. 2018.PubMed/NCBI

41 

Xie T, Wu D, Li S, Li X, Wang L, Lu Y, Song Q, Sun X and Wang X: microRNA-582 potentiates liver and lung metastasis of gastric carcinoma cells through the FOXO3-mediated PI3K/Akt/Snail pathway. Cancer Manag Res. 12:5201–5212. 2020. View Article : Google Scholar : PubMed/NCBI

42 

Chen ZF, Wang J, Yu Y and Wei W: MicroRNA-936 promotes proliferation and invasion of gastric cancer cells by down-regulating FGF2 expression and activating P13K/Akt signaling pathway. Eur Rev Med Pharmacol Sci. 24:6707–6715. 2020.PubMed/NCBI

43 

Jiang Q, Xing W, Cheng J and Yu Y: Knockdown of lncRNA XIST suppresses cell tumorigenicity in human non-small cell lung cancer by regulating miR-142-5p/PAX6 axis. Onco Targets Ther. 13:4919–4929. 2020. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhang Y, Chang J, Jiang W, Ye X and Zhang S: Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation. Oncol Lett 22: 544, 2021.
APA
Zhang, Y., Chang, J., Jiang, W., Ye, X., & Zhang, S. (2021). Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation. Oncology Letters, 22, 544. https://doi.org/10.3892/ol.2021.12805
MLA
Zhang, Y., Chang, J., Jiang, W., Ye, X., Zhang, S."Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation". Oncology Letters 22.1 (2021): 544.
Chicago
Zhang, Y., Chang, J., Jiang, W., Ye, X., Zhang, S."Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation". Oncology Letters 22, no. 1 (2021): 544. https://doi.org/10.3892/ol.2021.12805
Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Chang J, Jiang W, Ye X and Zhang S: Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation. Oncol Lett 22: 544, 2021.
APA
Zhang, Y., Chang, J., Jiang, W., Ye, X., & Zhang, S. (2021). Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation. Oncology Letters, 22, 544. https://doi.org/10.3892/ol.2021.12805
MLA
Zhang, Y., Chang, J., Jiang, W., Ye, X., Zhang, S."Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation". Oncology Letters 22.1 (2021): 544.
Chicago
Zhang, Y., Chang, J., Jiang, W., Ye, X., Zhang, S."Long non‑coding RNA CASC9/microRNA‑590‑3p axis participates in lutein‑mediated suppression of breast cancer cell proliferation". Oncology Letters 22, no. 1 (2021): 544. https://doi.org/10.3892/ol.2021.12805
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team